Assessment of serum Ischemia Modified Albumin (IMA) Levels in Acute Rheumatic Fever

Authors

  • Indranil Dawn Associate Professor, NRS Medical College, Department of Biochemistry, India
  • Gouranga Biswas Assistant Professor, Malda Medical College, Department of Paediatrics, India

DOI:

https://doi.org/10.31344/ijhhs.v5i2.263

Keywords:

Acute rheumatic fever, rheumatic heart disease, ischemia modified albumin

Abstract

Introduction : Rheumatic fever (RF) is an autoimmune, multiorgan inflammatory disease. The patients develop carditis (50-78%), arthritis (35-88%), chorea (2-19%), erythema marginatum (< 6%) and subcutaneous nodules (< 1-13%). Ischemia modified albumin or cobalt binding albumin is one of new biomarker for inflammation and oxidative stress. Various previous studies indicate that acute rheumatic fever is associated with oxidative stress and inflammation. In the present study, we examined IMA, CRP, ESR and albumin levels in acute rheumatic fever.

Material and method: This case control study was conductedbetween April 2017 to March 2018 in pediatrics department of Malda Medical College and Hospital. Study group composed of 42 children aged 5-18 years suffering from acute rheumatic fever diagnosed by modified jones criteria and they compared with 50 healthy age and sex match control. The IMA levels were compared among groups, and the association to acute phase reactants were investigated.

Results: Values ofserumischemia modified albumin, ESR and C Reactive Protein were significantly higher in cases compared to control group (p value ≤0.001). But no significant differencewas found between values of serum albumin in cases compared to control group. Positive correlation was found between cases serum IMA and ESR, C-Reactive protein.

Conclusion: Serumischemia modified albumin were significantly higher in children with acute rheumatic fever compared to control group, so IMA could be used as a biomarker in diagnosis of ARF. However, further multicenter and larger case studies are needed to provide stronger evidence.

International Journal of Human and Health Sciences Vol. 05 No. 02 April’21 Page: 222-225

Downloads

Published

2020-10-04

How to Cite

Dawn, I., & Biswas, G. (2020). Assessment of serum Ischemia Modified Albumin (IMA) Levels in Acute Rheumatic Fever. International Journal of Human and Health Sciences (IJHHS), 5(2), 222–225. https://doi.org/10.31344/ijhhs.v5i2.263

Issue

Vol. 5 No. 2 (2021)

Section

Original Articles

License

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.